 | Up a level |
Journal Article
Giebeler, N., Schoenefu, A., Landsberg, J., Tueting, T., Mauch, C. and Zigrino, P. (2016). ADAM-9 modulates melanoma development and metastasis in vivo. Exp. Dermatol., 25 (3). S. E38 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1600-0625
Giebeler, N., Schoenefuss, A., Landsberg, J., Tueting, T., Mauch, C. and Zigrino, P. (2017). ADAM9 modulates melanoma development and metastasis. J. Invest. Dermatol., 137 (10). S. S282 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1523-1747
Giebeler, N., Schoenefuss, A., Landsberg, J., Tuting, T., Mauch, C. and Zigrino, P. (2017). Deletion of ADAM-9 in HGF/CDK4 mice impairs melanoma development and metastasis. Oncogene, 36 (35). S. 5058 - 5068. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5594
Goltz, D., Gevensleben, H., Bootz, F., Kristiansen, G., Dietrich, D. and Landsberg, J. (2017). Prognostic significance of PDCD1 (PD-1), CD274 (PD-L1) and PDCD1LG2 (PDL2) promoter methylation for melanoma patients. Exp. Dermatol., 26 (3). S. E83 - 1. HOBOKEN: WILEY. ISSN 1600-0625
Goltz, D., Gevensleben, H., Kristiansen, G., Vogt, T., Hoffmann, F., Dietrich, D. and Landsberg, J. (2017). Prognostic significance and predictive value to anti-PD1 treatment of promoter methylation of PDCD1 (PD-1), CD274 (PD-L1) and PDCD1LG2 (PD-L2) for melanoma patients. J. Dtsch. Dermatol. Ges., 15. S. 2 - 3. HOBOKEN: WILEY. ISSN 1610-0387
Kunz, M., Dannemann, M., Dose, G., Kelso, J., Hoffmann, S., Landsberg, J., Tueting, T., Zigrino, P., Mauch, C., Kottek, T., Utikal, J., Schulze, H., Ziemer, M., Simon, J., Bosserhoff, A. and Schartl, M. (2017). RNA-Seq analysis of benign melanocytic nevi and primary melanomas. Exp. Dermatol., 26 (3). S. E86 - 1. HOBOKEN: WILEY. ISSN 1600-0625
Mescher, M., Jeong, P., Ruebsam, M., Kranen, M., Landsberg, J., Schlaak, M., Mauch, C., Tueting, T., Niessen, C. M. and Iden, S. (2016). Non-cell autonomous suppression of melanoma by the epidermal polarity protein Par3 through control of direct keratinocyte-melanocyte interactions. J. Invest. Dermatol., 136 (9). S. S244 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1523-1747
Mescher, M., Ruebsam, M., Jeong, P., Kranen, M., Landsberg, J., Schlaak, M., Mauch, C., Niessen, C. M., Tueting, T. and Iden, S. (2015). The epidermal polarity protein Par3 acts as non-cell autonomous suppressor of malignant melanoma. J. Invest. Dermatol., 135. S. S20 - 1. NEW YORK: NATURE PUBLISHING GROUP. ISSN 1523-1747
Moro, N., Schoenefuss, A., Landsberg, J., Tueting, T., Mauch, C. and Zigrino, P. (2014). ADAM-9 deletion in an animal model with spontaneous melanoma development reduces lung metastases formation. Exp. Dermatol., 23 (3). S. E43 - 2. HOBOKEN: WILEY-BLACKWELL. ISSN 1600-0625
Moro, N., Schoenefuss, A., Landsberg, J., Tueting, T., Mauch, C. and Zigrino, P. (2014). DELETION OF ADAM-9 IN AN ANIMAL MODEL WITH SPONTANEOUS MELANOMA DEVELOPMENT REDUCES LUNG METASTASIS FORMATION. Wound Repair Regen., 22 (5). S. A92 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1524-475X
Moro, N., Schoenefuss, A., Landsberg, J., Tueting, T., Mauch, C. and Zigrino, P. (2014). Dual role for ADAM-9 in melanoma development and metastasis in vivo. J. Invest. Dermatol., 134. S. S90 - 1. NEW YORK: NATURE PUBLISHING GROUP. ISSN 1523-1747
Moro, N., Schoenefuss, A., Landsberg, J., Tueting, T., Mauch, C. and Zigrino, P. (2015). Melanoma-derived ADAM-9 modulates melanoma development and metastasis in vivo. Exp. Dermatol., 24 (3). S. E39 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1600-0625
Moro, N., Schoenefuss, A., Landsberg, J., Tueting, T., Mauch, C. and Zigrino, P. (2015). Melanoma-derived ADAM-9 modulates melanoma development and metastasis in vivo. Exp. Dermatol., 24 (3). S. E39 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1600-0625
Voth, H., Landsberg, J., Hinz, T., Wenzel, J., Bieber, T., Reinhard, G., Hoeller, T., Wendtner, C. -M. and Schmid-Wendtner, M. -H. (2011). Management of dermatofibrosarcoma protuberans with fibrosarcomatous transformation: an evidence-based review of the literature. J. Eur. Acad. Dermatol. Venereol., 25 (12). S. 1385 - 1392. HOBOKEN: WILEY. ISSN 1468-3083